Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Erythematosus (SLE)

Oct 13, 2025

- Oct 12, 2026

1.25

Claim your AMA PRA Category 1 Credit(s), CNE Contact Hour(s), CPE Contact Hour(s) (CEUs) credit

Already have an Account? Log In
Don’t have an account? Register Today

Claim your Certificate

PCSK9 Inhibitors in Primary Prevention: A New Paradigm for Family Physicians

The Evolving Role of High Efficacy, Anti-CD40 Therapeutics for Relapsing Multiple Sclerosi...

Review of Biosimilar Therapeutics for Patients with Relapsing Multiple Sclerosis